RMC-6236 + cetuximab for colorectal or pancreatic cancer (RMC-GI-102_B) - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
[RMC-GI-102_B] Study of RMC-6236 in Combination with Cetuximab with or without mFOLFOX6 in Patients with Unresectable or Metastatic Colorectal Cancer or Metastatic Pancreatic Ductal Adenocarcinoma ? Subprotocol B
Principal Investigator
Medical Oncologist
Protocol Number
IRB:
PRO00115669
NCT:
NCT06445062
Phase
Phase
I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-668-1861
or email gi-oncology-cru@dm.duke.edu